175 related articles for article (PubMed ID: 32704040)
1. Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.
Li Z; Zhu YT; Xiang M; Qiu JL; Luo SQ; Lin F
Acta Pharmacol Sin; 2021 Apr; 42(4):624-632. PubMed ID: 32704040
[TBL] [Abstract][Full Text] [Related]
2. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
Hong W; Shi H; Qiao M; Gao X; Yang J; Tian C; Zhang D; Niu S; Liu M
Int J Nanomedicine; 2017; 12():989-1007. PubMed ID: 28243082
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.
Han ML; Zhao YF; Tan CH; Xiong YJ; Wang WJ; Wu F; Fei Y; Wang L; Liang ZQ
Acta Pharmacol Sin; 2016 Dec; 37(12):1606-1622. PubMed ID: 27840408
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
5. A lysosome independent role for TFEB in activating DNA repair and inhibiting apoptosis in breast cancer cells.
Slade L; Biswas D; Ihionu F; El Hiani Y; Kienesberger PC; Pulinilkunnil T
Biochem J; 2020 Jan; 477(1):137-160. PubMed ID: 31820786
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
Zhitomirsky B; Assaraf YG
Oncotarget; 2015 Jan; 6(2):1143-56. PubMed ID: 25544758
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells.
Fang LM; Li B; Guan JJ; Xu HD; Shen GH; Gao QG; Qin ZH
Acta Pharmacol Sin; 2017 Sep; 38(9):1305-1316. PubMed ID: 28603284
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel enhances lysosomal function through TFEB activation.
Zhang J; Wang J; Wong YK; Sun X; Chen Y; Wang L; Yang L; Lu L; Shen HM; Huang D
Cell Death Dis; 2018 May; 9(6):614. PubMed ID: 29795139
[TBL] [Abstract][Full Text] [Related]
9. Silver nanoparticles induce lysosomal-autophagic defects and decreased expression of transcription factor EB in A549 human lung adenocarcinoma cells.
Miyayama T; Fujiki K; Matsuoka M
Toxicol In Vitro; 2018 Feb; 46():148-154. PubMed ID: 28987793
[TBL] [Abstract][Full Text] [Related]
10. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Duarte D; Nunes M; Ricardo S; Vale N
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
[TBL] [Abstract][Full Text] [Related]
11. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.
Bartlett JJ; Trivedi PC; Yeung P; Kienesberger PC; Pulinilkunnil T
Biochem J; 2016 Nov; 473(21):3769-3789. PubMed ID: 27487838
[TBL] [Abstract][Full Text] [Related]
13. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.
Kundu ST; Grzeskowiak CL; Fradette JJ; Gibson LA; Rodriguez LB; Creighton CJ; Scott KL; Gibbons DL
Nat Commun; 2018 Jul; 9(1):2731. PubMed ID: 30013069
[TBL] [Abstract][Full Text] [Related]
14. Acid-Sensitive Peptide-Conjugated Doxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses Drug Resistance in Breast Cancer.
Sheng Y; Xu J; You Y; Xu F; Chen Y
Mol Pharm; 2015 Jul; 12(7):2217-28. PubMed ID: 26035464
[TBL] [Abstract][Full Text] [Related]
15. Bafilomycin A1 increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin by inhibiting the lysosomal uptake of platinum ions but not autophagy.
Chu HY; Wang W; Chen X; Jiang YE; Cheng R; Qi X; Zhong ZM; Zeng MS; Zhu XF; Sun CZ
Cancer Lett; 2018 Jun; 423():105-112. PubMed ID: 29524554
[TBL] [Abstract][Full Text] [Related]
16. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production.
Hamacher-Brady A; Stein HA; Turschner S; Toegel I; Mora R; Jennewein N; Efferth T; Eils R; Brady NR
J Biol Chem; 2011 Feb; 286(8):6587-601. PubMed ID: 21149439
[TBL] [Abstract][Full Text] [Related]
17. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin L-mediated resistance of paclitaxel and cisplatin is mediated by distinct regulatory mechanisms.
Zhao Y; Shen X; Zhu Y; Wang A; Xiong Y; Wang L; Fei Y; Wang Y; Wang W; Lin F; Liang Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):333. PubMed ID: 31370861
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.
Fedele AO; Proud CG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32285908
[TBL] [Abstract][Full Text] [Related]
20. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
